Operator of an advanced embryo screening company intended for prospective parents to assess genetic risk and trait likelihood before implantation. Herasight is based in Wilmington, DE.
Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—
Funding — no rounds on record
No funding rounds for Herasight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Herasight with a free account
·Watch Herasight: the Monday email on marks, rounds and moves
